Delineation of autoantibody repertoire through differential proteogenomics in hepatitis C virus-induced cryoglobulinemia

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ogishi, Masato ^a   Yotsuyanagi, Hiroshi ^a   Moriya, Kyoji ^a   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN;

CRYOGLOBULINEMIA; HEPACIVIRUS; HEPATITIS C; HUMAN; IMMUNOLOGY; PROCEDURES; PROTEOGENOMICS; VIROLOGY;

AUTOANTIBODIES; CRYOGLOBULINEMIA; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; PROTEOGENOMICS;

EID: 84978410092     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29532     Document Type: Article

References (46)

1. Sansonno, D. & Dammacco, F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet. Infect. Dis. 5, 227-236 (2005).
2. Nobakht, E., Cohen, S. D., Rosenberg, A. Z. & Kimmel, P. L. HIV-associated immune complex kidney disease. Nat. Rev. Nephrol. 12, 291-300 (2016).
3. Liu, M. et al. Polyreactivity and autoreactivity among HIV-1 antibodies. J. Virol. 89, 784-798 (2015).
4. Ross, P. L. et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3, 1154-1169 (2004).
5. Cheung, W. C. et al. A proteomics approach for the identification and cloning of monoclonal antibodies from serum. Nat. Biotechnol. 30, 447-452 (2012).
6. Sato, S. et al. Proteomics-directed cloning of circulating antiviral human monoclonal antibodies. Nat. Biotechnol. 30, 1039-1043 (2012).
7. Boutz, D. R. et al. Proteomic identification of monoclonal antibodies from serum. Anal. Chem. 86, 4758-4766 (2014).
8. Shugay, M. et al. Towards error-free profiling of immune repertoires. Nat. Methods 11, 653-655 (2014).
9. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteomewide protein quantification. Nat. Biotechnol. 26, 1367-1372 (2008).
10. Chan, C. H., Hadlock, K. G., Foung, S. K. & Levy, S. V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 97, 1023-1026 (2001).
11. Breden, F. et al. Comparison of antibody repertoires produced by HIV-1 infection, other chronic and acute infections, and systemic autoimmune disease. PLoS One 6, e16857 (2011).
12. Perotti, M. et al. Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia. Autoimmun. Rev. 7, 468-472 (2008).
13. Davies, J. & Riechmann, L. Affinity improvement of single antibody VH domains: Residues in all three hypervariable regions affect antigen binding. Immunotechnology 2, 169-179 (1996).
14. Sansonno, D. et al. Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia. Clin. Exp. Immunol. 133, 275-282 (2003).
15. De Re, V. et al. HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations. Leukemia 20, 1145-1154 (2006).
16. Uhlen, M. et al. Tissue-based map of the human proteome. Science (80-. ). 347, 1260419 (2015).
17. Mouquet, H. et al. Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature 467, 591-595 (2010).
18. Krey, T. et al. Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape. PLoS Pathog. 9, e1003364 (2013).
19. Sautto, G., Tarr, A. W., Mancini, N. & Clementi, M. Structural and antigenic definition of hepatitis C virus e2 glycoprotein epitopes targeted by monoclonal antibodies. Clin. Dev. Immunol. 2013, 450963 (2013).
20. Ball, J. K., Tarr, A. W. & McKeating, J. a. The past, present and future of neutralizing antibodies for hepatitis C virus. Antiviral Res. 105, 100-111 (2014).
21. Eroshkin, A. M. et al. bNAber: database of broadly neutralizing HIV antibodies. Nucleic Acids Res. 42, D1133-D1139 (2014).
22. Giudicelli, V. et al. IMGT/LIGM-DB, the IMGT comprehensive database of immunoglobulin and T cell receptor nucleotide sequences. Nucleic Acids Res. 34, D781-D784 (2006).
23. Clemente-Casares, X. et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature 530, 434-440 (2016).
24. Münz, C., Lünemann, J. D., Getts, M. T. & Miller, S. D. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat. Rev. Immunol. 9, 246-258 (2009).
25. Fujinami, R. S., Herrath, M. G. Von, Christen, U. & Whitton, J. L. Molecular Mimicry, Bystander Activation, or Viral Persistence : Infections and Autoimmune Disease Molecular Mimicry, Bystander Activation, or Viral Persistence : Infections and Autoimmune Disease. Clin. Microbiol. Rev. 19, 80-94 (2006).
26. Mouquet, H., Warncke, M., Scheid, J. F., Seaman, M. S. & Nussenzweig, M. C. Enhanced HIV-1 neutralization by antibody heteroligation. Proc. Natl. Acad. Sci. USA 109, 875-880 (2012).
27. Mroczek, E. S. et al. Differences in the composition of the human antibody repertoire by B cell subsets in the blood. Front. Immunol. 5, 96 (2014).
28. Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374-1377 (2003).
29. Briney, B. S., Willis, J. R. & Crowe, J. E. Human peripheral blood antibodies with long HCDR3s are established primarily at original recombination using a limited subset of germline genes. PLoS One 7, e36750 (2012).
30. Penin, F. et al. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J. Virol. 75, 5703-5710 (2001).
31. Mulvihill, M. M. et al. Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity. Chem. Biol. 21, 831-840 (2014).
32. Kohnz, R. a. et al. Activity-Based Protein Profiling of Oncogene-Driven Changes in Metabolism Reveals Broad Dysregulation of PAFAH1B2 and 1B3 in Cancer. ACS Chem. Biol. 10, 1624-1630 (2015).
33. Diamond, D. L. et al. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog. 6, e1000719 (2010).
34. Ueda, T. et al. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling. Genomics 101, 238-248 (2013).
35. Lauletta, G. et al. Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study. Medicine (Baltimore). 92, 245-256 (2013).
36. R Core Team (2016). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/.
37. Wolfram Research, Inc. Mathematica, Champaign, IL. URL https://www.wolfram.com/mathematica/ (2016).
38. Motyckova, G. & Murali, M. Laboratory testing for cryoglobulins. Am. J. Hematol. 86, 500-502 (2011).
39. Picelli, S. et al. Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Nat. Methods 10, 1096-1098 (2013).
40. Matz, M. et al. Amplification of cDNA ends based on template-switching effect and step-out PCR. Nucleic Acids Res. 27, 1558-1560 (1999).
41. Alamyar, E., Duroux, P., Lefranc, M.-P. & Giudicelli, V. IMGT(®) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS. Methods Mol. Biol. 882, 569-604 (2012).
42. Davies, J. & Riechmann, L. 'Camelising' human antibody fragments: NMR studies on VH domains. FEBS Lett. 339, 285-290 (1994).
43. Rouet, R., Lowe, D. & Christ, D. Stability engineering of the human antibody repertoire. FEBS Lett. 588, 269-277 (2014).
44. Djender, S., Beugnet, A., Schneider, A. & de Marco, A. The Biotechnological Applications of Recombinant Single-Domain Antibodies are Optimized by the C-Terminal Fusion to the EPEA Sequence (C Tag). Antibodies 3, 182-191 (2014).
45. Mizukami, M. et al. Highly efficient production of VHH antibody fragments in Brevibacillus choshinensis expression system. Protein Expr. Purif. 105, 23-32 (2015).
46. Yaari, G., Uduman, M. & Kleinstein, S. H. Quantifying selection in high-throughput Immunoglobulin sequencing data sets. Nucleic Acids Res. 40, 10-12 (2012).